Northwest Biotherapeutics | NWBO - Ebitda





Ebitda Cambio Fecha
Agenus USD -10.11M 19.02M 2025-03
AstraZeneca USD 7.46B 2.3B 2026-09
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Celldex Therapeutics USD -79.72M 3.86M 2026-06
Eisai JPY 25.94B 8.21B 2026-09
Merck USD 1.42B 2.97B 2026-06
Northwest Biotherapeutics USD -13.41M 232K 2023-09
Pfizer USD 6.36B 350M 2026-09
Plus Therapeutics USD -4.4M 2.94M 2025-09
Roche Holding CHF 13.43B 744M 2026-06